Wells Fargo’s Pharming Group PHAR Stock Holding History

Wells Fargo’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-974	Closed	-$9K	–	7312
2022 Q1	$9K	Buy	+974	New	+$8.64K	﹤0.01%	6312

Other funds holding PHAR

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's PHAR Position: Q2 2022 in Review

Wells Fargo sold out of Pharming Group (PHAR) in Q2 2022, closing a stake of 974 shares — an estimated $9K sold.

Wells Fargo first reported a position in PHAR in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 3 funds tracked by Wall St. Rank hold PHAR as of Q2 2022.

Wells Fargo reported no remaining Pharming Group position as of Q2 2022 after selling out during the quarter.
Wells Fargo sold 974 Pharming Group shares in Q2 2022, an estimated $9K.
Wells Fargo first reported a position in Pharming Group in Q1 2022 and held it in 1 quarter.
Wells Fargo's Pharming Group position peaked at $9K in Q1 2022.
3 funds tracked by Wall St. Rank held Pharming Group as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.